Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9978944 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 11 Pages |
Abstract
These results suggest that aprotinin provides protection from renal ischemia-reperfusion injury. They also suggest that aprotinin may do so by affecting apoptotic signaling and inflammatory cytokine production. Aprotinin is a potential therapeutic measure in clinical situations where renal ischemia-reperfusion injury can be anticipated, provided adequate heparinization is possible.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ajay MD, Kirstan K. MD, Karen L. BS, Meijing MD, Ben M. MD, Mark W. MD, John W. MD, Daniel R. MD,